Bulletin
Investor Alert

press release

March 2, 2022, 8:30 a.m. EST

ICU Medical, Inc. to Participate at the Raymond James 43rd Annual Institutional Investors Conference

SAN CLEMENTE, Mar 02, 2022 (GLOBE NEWSWIRE via COMTEX) -- SAN CLEMENTE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. /zigman2/quotes/208026181/composite ICUI +2.50% , a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Raymond James 43 [r] [d] Annual Institutional Investors Conference at 11:15 a.m. PT (2:15 p.m. ET) on Tuesday, March 8, 2022.

About ICU Medical, Inc.

ICU Medical /zigman2/quotes/208026181/composite ICUI +2.50% is a global leader in infusion systems, infusion consumables, and high-value critical care products used in hospital, alternate site, and home care settings. Our team is focused on providing quality, innovation, and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. For more information about ICU Medical, go to www.icumed.com and follow us on LinkedIn , Twitter , and Facebook .

CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183

ICR, Inc.
John Mills, Managing Partner
(646) 277-1254

Source: ICU Medical, Inc.

COMTEX_403371430/2471/2022-03-02T08:30:29

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2022 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/208026181/composite
US : U.S.: Nasdaq
$ 169.42
+4.13 +2.50%
Volume: 214,252
June 24, 2022 4:00p
P/E Ratio
82.94
Dividend Yield
N/A
Market Cap
$3.95 billion
Rev. per Employee
$181,339
loading...
/zigman2/quotes/208026181/composite
US : U.S.: Nasdaq
$ 169.42
+4.13 +2.50%
Volume: 214,252
June 24, 2022 4:00p
P/E Ratio
82.94
Dividend Yield
N/A
Market Cap
$3.95 billion
Rev. per Employee
$181,339
loading...

Partner Center

Link to MarketWatch's Slice.